Mehiar El-Hamdani is a Cardiology physician affiliated with Marshall University. OpenAlex indexes 52 publications with 486 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
67.5%Beta blocker16.2%Metoprolol Succinate72%Metoprolol Tartrate12%Carvedilol12%Atenolol4%Part D<11 patientsStatin10.5%Atorvastatin Calcium53%Rosuvastatin Calcium34%Simvastatin7%Pravastatin Sodium6%Part D<11 patients+ 12 more classes in this area
Blood & clotting
30.9%Vitamin K antagonist14%Warfarin Sodium89%Jantoven11%Part D<11 patientsP2Y12 inhibitor7.4%Clopidogrel94%Prasugrel Hcl6%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
1.7%Proton pump inhibitor0.7%Omeprazole100%Part D<11 patientsPotassium supplement0.5%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
David Gozal, MD
Marshall University
Matias Valsecchi, MD
Marshall University
Khalid Abozguia, MD, PhD
Marshall University
James Gigantelli, MD
Marshall University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”